Treatment with antibodies to leucocyte function-associated antigen-1 prolongs the survival of xenotransplanted islets of Langerhans.
Bühler
L
L
Department of Surgery, University Hospital Geneva, Switzerland.
Deng
S
S
Grau
G
G
Mentha
G
G
Rohner
A
A
Morel
P
P
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D007074:Immunoglobulin G / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000473:pathology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D017207:Rats, Sprague-Dawley; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D016169:Lymphocyte Function-Associated Antigen-1